Progress comes when we stop driving down the middle and start finding the edge.

Convergent research advances science — convergent thinking can stall it.

Healthcare costs aren’t mysterious — they’re the product of design, incentives, and engagement.

Power abroad begins with stability at home — context decides credibility.

Just like racing, in my cancer world, I need to get the research car in the best position possible before I turn it over to the closing driver – maybe that’s NIH, a drug company, or someone else. But we have to build momentum if we want a chance to win. That’s why I’m working and investing in the early stages  of the research race.

Only focusing on one or two legs doesn’t get us where we need to be as fast as needed. This is kind of how cancer treatment development and research works. Think of it like a cancer relay race.